Electromed, Inc.

ELMD Healthcare Medical Devices

Electromed, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $73.8 million, up 15.3% from fiscal 2025. In the quarter to June 2026, revenue grew 11.6%, EPS grew 57.7% and free cash flow fell 25.2%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.

27.42 0.61 −2.18%
Market cap
$232.3M
P/E
20.0×
Fwd P/E
25.5×
Dividend yield
—
F-score
8/9
Altman Z
20.30
Beneish M
−2.20
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Total current assets
57.37 50.23 45.57 44.56
Total non-current assets
8.90 9.25 9.34 9.06
Total Assets
66.27 59.47 54.91 53.61
Total current liabilities
12.22 10.23 9.38 8.76
Total non-current liabilities
0.07 0.08 0.10 0.11
Total liabilities
12.29 10.31 9.47 8.87
Common Equity (Total)
53.98 49.17 45.44 44.75
Shareholders Equity (Total)
53.98 49.17 45.44 44.75

Show all line items

In millions of $ except per-share values · columns are period end dates